China halts sale of Sun Pharma drug used to treat dementia
The National Medical Products Administration said a recent remote inspection found shortcomings in the company’s production processes, including in the prevention of contamination anfulfilmentd the quality management department’s fulfillment of duties.
The National Medical Products Administration said a recent remote inspection found shortcomings in the company’s production processes, including in the prevention of contamination anfulfilmentd the quality management department’s fulfillment of duties.
What's Your Reaction?
